Subject(s)
Liver Diseases/surgery , Pancreatic Ducts/surgery , Pancreatic Fistula/surgery , Portal Vein/surgery , Cholangiopancreatography, Magnetic Resonance , Female , Humans , Liver Diseases/diagnostic imaging , Liver Diseases/etiology , Middle Aged , Necrosis/diagnostic imaging , Necrosis/etiology , Necrosis/surgery , Pancreatic Ducts/diagnostic imaging , Pancreatic Fistula/complications , Pancreatic Fistula/diagnostic imaging , Portal Vein/diagnostic imaging , Stents , Tomography, X-Ray Computed , Treatment OutcomeSubject(s)
Anti-Bacterial Agents/therapeutic use , Cholangiopancreatography, Endoscopic Retrograde , Drainage , Jaundice, Obstructive/therapy , Pancreatic Fistula/therapy , Pancreatic Pseudocyst/therapy , Portal Vein/diagnostic imaging , Stents , Cholangiopancreatography, Magnetic Resonance , Common Bile Duct/diagnostic imaging , Female , Humans , Imaging, Three-Dimensional , Jaundice, Obstructive/etiology , Middle Aged , Pancreatic Fistula/diagnostic imaging , Pancreatic Fistula/etiology , Pancreatic Pseudocyst/diagnostic imaging , Pancreatic Pseudocyst/etiology , Pancreatitis , Tomography, X-Ray Computed , Ultrasonography, Doppler, ColorABSTRACT
INTRODUCTION: Breath testing (BT) has gained interest for diagnosing small intestinal bacterial overgrowth (SIBO) in IBD patients with irritable bowel syndrome (IBS) overlap. We aim to characterize the rate of SIBO and BT gas patterns in IBD patients with IBS-like symptoms compared to non-IBD patients. METHODS: A database of 14,847 consecutive lactulose BTs was developed from patients with IBS-like symptoms between November 2005 and October 2013. BTs were classified as normal, H2 predominant, CH4 predominant, and flatline based on criteria established from the literature. BT data linkage with electronic health records and chart review identified IBD patients along with disease phenotype, location, severity, and antibiotic response. Poisson loglinear model evaluated differences in gas patterns between the two groups. RESULTS: After excluding patients with repeat breath tests, we identified 486 IBD and 10,505 non-IBD patients with at least one BT. Positive BT was present in 57% (n = 264) of IBD patients. Crohn's disease (odds ratio (OR) 0.21, [95% confidence interval (CI) 0.11-0.38]) and ulcerative colitis (OR 0.39, [95% CI 0.22-0.70]) patients were less likely to produce excess CH4. IBD patients were more likely to have flatline BT (OR 1.82, [95% CI 1.20-2.77]). In IBD patients with SIBO, 57% improved symptomatically with antibiotics. CONCLUSION: In a cohort of IBD patients with IBS-like symptoms, a high rate of patients had positive BT and symptomatic improvement with antibiotics. In IBD, methanogenesis is suppressed and flatline BT is more frequent, suggesting excess hydrogenotrophic bacteria. These findings suggest methanogenic and hydrogenotrophic microorganisms as potential targets for microbiome-driven biomarkers and therapies.
Subject(s)
Anti-Bacterial Agents/therapeutic use , Dysbiosis/complications , Inflammatory Bowel Diseases/microbiology , Irritable Bowel Syndrome/microbiology , Adult , Aged , Breath Tests , Cross-Sectional Studies , Dysbiosis/diagnosis , Female , Humans , Inflammatory Bowel Diseases/complications , Inflammatory Bowel Diseases/drug therapy , Irritable Bowel Syndrome/complications , Male , Middle Aged , Retrospective StudiesSubject(s)
Carcinoma, Signet Ring Cell/diagnosis , Colonic Neoplasms/diagnosis , Esophageal Diseases/diagnosis , Carcinoma, Signet Ring Cell/complications , Carcinoma, Signet Ring Cell/pathology , Carcinoma, Signet Ring Cell/therapy , Colonic Neoplasms/complications , Colonic Neoplasms/pathology , Colonic Neoplasms/therapy , Colonoscopy , Endoscopy, Digestive System , Esophageal Diseases/complications , Esophageal Diseases/pathology , Humans , Male , Middle AgedABSTRACT
BACKGROUND: Patients with inflammatory bowel disease (IBD) are at risk for psychiatric disorders that impact symptom experience and health-related quality of life (HRQOL). Therefore, comprehensive biopsychosocial assessments should be considered in ambulatory care settings. Patient-Reported Outcomes Measurement Information System (PROMIS) measures created by the National Institutes of Health have shown construct validity in a large IBD internet-based cohort, but their validity in ambulatory settings has not been examined. We sought to validate PROMIS patient-reported measures of HRQOL, functioning, and psychiatric symptom severity at a tertiary IBD clinic. METHODS: Adult patients (n = 110) completed the PROMIS Global Health scale, PROMIS-29, SF-12, and WHODAS 2.0. Pearson's correlation coefficients (r) determined the relationships between scores to validate the PROMIS Global Health Physical and Mental metrics, compared with the SF-12 and WHODAS 2.0. We compared these measures by disease subtype of Crohn's disease or ulcerative colitis. RESULTS: PROMIS measures were highly correlated (r range = 0.64-0.82) with standard measures of HRQOL and functioning. On the PROMIS Global Health measures, 20.9% had impaired physical health, and 13.7% had impaired mental health. Impairments were reported in pain interference (20% of patients), anxiety (18.2%), satisfaction with social role (15.5%), physical functioning (10.9%), fatigue (10%), depression (7.3%), and sleep disturbance (5.5%). Patients with Crohn's disease had worse scores than those with ulcerative colitis on measures of the global physical health (P = 0.027), physical functioning (P = 0.047), and pain interference (P = 0.0009). CONCLUSIONS: PROMIS instruments provide valid assessment of HRQOL and functioning in ambulatory adults with IBD. Of note, patients with Crohn's disease demonstrated significantly worse impairments than those with ulcerative colitis.